Back
Novo Nordisk AS 10K Form
Sell
18
NONOF
Novo Nordisk AS
Last Price:
$62.16
Seasonality Move:
4.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NONOF News And Ratings
See the #1 stock for the next 7 days that we like better than NONOF
NONOF Financial Statistics
Sales & Book Value
| Annual Sales: | $42.1B |
|---|---|
| Cash Flow: | $-786.4M |
| Price / Cash Flow: | 27.44 |
| Annual Sales: | $4.51 |
| Price / Book: | 13.78 |
Profitability
| EPS (TTM): | 3.28330 |
|---|---|
| Net Income (TTM): | $14.7B |
| Gross Margin: | $35.7B |
| Return on Equity: | 86.85% |
| Return on Assets: | 27.39% |
Novo Nordisk AS Earnings Forecast
Key Novo Nordisk AS Financial Ratios
-
The Gross Profit Margin over the past 41 years for NONOF is 84.67%.
-
The Selling, General & Administrative Expenses for NONOF have been equal to 23.20% of Gross Profit Margin.
-
The Research & Development expenses have been 16.55% of Revenue.
-
The Interest Expense is 1.62% of Operating Income.
-
The Net Earning history of NONOF is 34.78% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 36 years.
Novo Nordisk AS Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NONOF |
| Website: | novonordisk.com |
Debt
| Debt-to-Equity Ratio: | 0.67 |
|---|---|
| Current Ratio: | 0.74 |
| Quick Ratio: | 0.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.93 |
|---|---|
| Forward P/E Ratio: | 0 |
NONOF Technical Analysis vs Fundamental Analysis
Sell
18
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a SellThe current Novo Nordisk AS [NONOF] share price is $62.16. The Score for NONOF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.